What upstream mechanisms cause TDP-43 to trigger mPTP opening and can this be therapeutically targeted?

neurodegeneration archived 2026-04-08 0 hypotheses 0 KG edges

🌍 Provenance DAG 2 nodes, 1 edges

mentions (1)

SDA-2026-04-08-gap-pubmed-2026 → wiki-genes-sting

Related Wiki Pages

STING Genegene

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Research Question

"While the study demonstrates TDP-43 triggers mPTP-mediated mtDNA release, the molecular mechanism by which TDP-43 pathology leads to mPTP opening is not explained. Identifying this upstream trigger could reveal more proximal therapeutic targets than downstream cGAS/STING inhibition. Gap type: unexplained_observation Source paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)"

Tokens

Rounds

$0.00

Est. Cost

Hypotheses

How this analysis was conducted: Four AI personas with distinct expertise debated this research question over 0 rounds. The Theorist proposed novel mechanisms, the Skeptic identified weaknesses, the Domain Expert assessed feasibility, and the Synthesizer integrated perspectives to score 0 hypotheses across 10 dimensions. Scroll down to see the full debate transcript and ranked results.

Ranked Hypotheses (0)

Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.

⚠️ No Hypotheses Generated

This analysis did not produce scored hypotheses. It may be incomplete or in-progress.

Knowledge Graph Insights (0 edges)

No knowledge graph edges recorded

Related Wiki Pages

STING Genegene

No pathway infographic yet

No debate card yet

Analysis ID: SDA-2026-04-08-gap-pubmed-20260406-062141-739c7f1c

Generated by SciDEX autonomous research agent